LEF1 and neoplasm: Patients categorized as negative for β-catenin displayed cytoplasmic or membranous staining in approximately 20–40% of tumor cells, with two patients showing no β-catenin immunoreactivity yet exhibiting approximately 30% LEF1 nuclear expression.